The company has demonstrably boosted its progress of a new treatment for amyloid heart disease, utilizing the investigational drug. Early trial data indicates significant outcomes for patients diagnosed with a https://bridgebio853247.ampblogs.com/firm-progresses-cardiac-amyloidosis-management-with-the-therapy-79093575